Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.

作者: Derek A. Wainwright , Craig M. Horbinski , Rintaro Hashizume , C. David James

DOI: 10.1007/S13311-017-0523-1

关键词:

摘要: The development and application of rodent models for preclinical testing novel therapeutics approaches treating brain tumors has been a mainstay neuro-oncology research decades, is likely to remain so into the foreseeable future. These serve as an important point entry analyzing potential efficacy experimental therapies that are being considered clinical trial evaluation. Although tumor have seen substantial change, particularly since introduction genetically engineered mouse models, certain principles associated with use these therapeutic enduring, form basis this review. Here we discuss most common while directing specific attention their usefulness in evaluation therapies. include mice spontaneously or inducibly develop tumors; syngeneic which cultured cells engrafted same strain from they were derived; patient-derived xenograft human immunocompromised rodents. emphasis review directed latter.

参考文章(55)
David J Monsma, Dawna Dylewski, Aaron D Sayfie, Martin Luchtefeld, Galen Hostetter, Paul Stephenson, Katie R Martin, Stephanie B Scott, Danielle M Burgenske, Nadav Dujovny, Jeffrey P MacKeigan, Donald G Kim, Establishment of genetically diverse patient-derived xenografts of colorectal cancer. American Journal of Cancer Research. ,vol. 4, pp. 824- 837 ,(2014)
Jana Karaskova, David H. Gutmann, Luba Roncari, Luba Roncari, Patrick Shannon, Andras Nagy, Abhijit Guha, Abhijit Guha, Abhijit Guha, Jeremy A. Squire, Xiaoli Wu, Nelson Lau, Nelson Lau, Hao Ding, Astrocyte-specific Expression of Activated p21-ras Results in Malignant Astrocytoma Formation in a Transgenic Mouse Model of Human Gliomas Cancer Research. ,vol. 61, pp. 3826- 3836 ,(2001)
Hidehiro Takei, Emilie Rouah, Yusuke Ishida, Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications. Brain Tumor Pathology. ,vol. 33, pp. 1- 12 ,(2016) , 10.1007/S10014-015-0235-3
Vogelstein B, Bigner Dd, Friedman Hs, Bigner Sh, Oakes Wj, Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Research. ,vol. 50, pp. 2347- 2350 ,(1990)
Oren J. Becher, Eric C. Holland, Genetically Engineered Models Have Advantages over Xenografts for Preclinical Studies Cancer Research. ,vol. 66, pp. 3355- 3359 ,(2006) , 10.1158/0008-5472.CAN-05-3827
Barbara Klink, Hrvoje Miletic, Daniel Stieber, Peter C Huszthy, Jaime Alberto Campos Valenzuela, Jörg Balss, Jian Wang, Manja Schubert, Per Øystein Sakariassen, Terje Sundstrøm, Anja Torsvik, Mads Aarhus, Rupavathana Mahesparan, Andreas von Deimling, Lars Kaderali, Simone P Niclou, Evelin Schröck, Rolf Bjerkvig, Janice M Nigro, None, A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1 PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0059773
Ewa M. Nowosielska, Aneta Cheda, Jolanta Wrembel-Wargocka, Marek K. Janiak, Effect of low doses of low-let radiation on the innate anti-tumor reactions in radioresistant and radiosensitive mice. Dose-response. ,vol. 10, pp. 500- 515 ,(2012) , 10.2203/DOSE-RESPONSE.12-018.NOWOSIELSKA
Jian Wang, Hrvoje Miletic, Per Ø Sakariassen, Peter C Huszthy, Hege Jacobsen, Narve Brekkå, Xingang Li, Peng Zhao, Sverre Mørk, Martha Chekenya, Rolf Bjerkvig, Per Ø Enger, None, A reproducible brain tumour model established from human glioblastoma biopsies BMC Cancer. ,vol. 9, pp. 465- 465 ,(2009) , 10.1186/1471-2407-9-465